Advertisement

The Latest

The University of Texas MD Anderson Cancer Center, Invectys and the Cell Therapy Manufacturing Center entered a strategic collaboration last week to develop a "reliable, compliant and scalable" process for human leukocyte antigen CAR-T cell therapy for solid tumors. 

Six hospitals and health systems that have opened specialty cancer facilities or shared plans to open new centers since April: 

Advertisement